May 9, 2018 / 12:15 PM / 6 months ago

BRIEF-Lodo Therapeutics - Has Formed A Strategic Drug Discovery Collaboration With Genentech

May 9 (Reuters) - Roche Holding AG:

* LODO THERAPEUTICS - HAS FORMED A STRATEGIC DRUG DISCOVERY COLLABORATION WITH GENENTECH, A MEMBER OF ROCHE GROUP

* LODO THERAPEUTICS - UNDER AGREEMENT, GENENTECH WILL UTILIZE CO’S PROPRIETARY GENOME MINING AND BIOSYNTHETIC CLUSTER ASSEMBLY PLATFORM

* LODO THERAPEUTICS - WILL RECEIVE UNDISCLOSED UPFRONT PAYMENT, ELIGIBLE TO RECEIVE MILESTONE PAYMENTS UP TO $969 MILLION FROM DEAL

* LODO THERAPEUTICS - IS ELIGIBLE TO RECEIVE TIERED-ROYALTIES ON SALES OF CERTAIN PRODUCTS RESULTING FROM COLLABORATION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below